Working… Menu

Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy (CYCHE2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00048386
Recruitment Status : Completed
First Posted : November 1, 2002
Last Update Posted : July 27, 2012
Baylor College of Medicine
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Malcolm Brenner, Baylor College of Medicine

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2004
Actual Study Completion Date : October 2009